Key facts
- It has raised $80K; the latest was Early Stage VC in Sep 2025.
- Notable investors include MassChallenge, EIT Food, Coller School of Management, Dan Launchpad, Road2 Innovation.
- Status: Privately Held (backing).
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for Rosalind Bioculture
- ·The full record, as it builds
Funding rounds
No funding rounds for Rosalind Bioculture are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Rosalind Bioculture
Developer of precision fermentation technologies designed for sustainable protein production. The company offers engineered microorganisms and novel fermentation technologies, turning everyday ingredients into potent fermented drinks naturally enhanced with beneficial bioactives, enabling the food industry to produce sustainable proteins at scale.
- Sector
- Consumer Products and Services (B2C)
- HQ
- Israel
- Founded
- 2024
- Employees
- 2
- Website
- ros.bio/
- Ownership
- Privately Held (backing)
Rosalind Bioculture doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Rosalind Bioculture shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Rosalind Bioculture in its N-PORT filings yet. We sweep new filings monthly.